Global CD38 Monoclonal Antibodies Market Size, Status and Forecast 2020-2026

August 2020 | 93 pages | ID: G6404051FB28EN
QYResearch

Abstracts

CD38 Monoclonal Antibodies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global CD38 Monoclonal Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study

• Johnson & Johnson
• Sanofi
• Janssen Biotech
• Carbosynth
• Creative Biolabs
• BOC Sciences

Market segment by Type, the product can be split into

• Daratumumab
• Isatuximab

Market segment by Application, split into

• Pharmacy
• Laboratory Use

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by CD38 Monoclonal Antibodies Revenue
1.4 Market by Type
  1.4.1 Global CD38 Monoclonal Antibodies Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Daratumumab
  1.4.3 Isatuximab
1.5 Market by Application
  1.5.1 Global CD38 Monoclonal Antibodies Market Share by Application: 2020 VS 2026
  1.5.2 Pharmacy
  1.5.3 Laboratory Use
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global CD38 Monoclonal Antibodies Market Perspective (2015-2026)
2.2 Global CD38 Monoclonal Antibodies Growth Trends by Regions
  2.2.1 CD38 Monoclonal Antibodies Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 CD38 Monoclonal Antibodies Historic Market Share by Regions (2015-2020)
  2.2.3 CD38 Monoclonal Antibodies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 CD38 Monoclonal Antibodies Market Growth Strategy
  2.3.6 Primary Interviews with Key CD38 Monoclonal Antibodies Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top CD38 Monoclonal Antibodies Players by Market Size
  3.1.1 Global Top CD38 Monoclonal Antibodies Players by Revenue (2015-2020)
  3.1.2 Global CD38 Monoclonal Antibodies Revenue Market Share by Players (2015-2020)
  3.1.3 Global CD38 Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global CD38 Monoclonal Antibodies Market Concentration Ratio
  3.2.1 Global CD38 Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by CD38 Monoclonal Antibodies Revenue in 2019
3.3 CD38 Monoclonal Antibodies Key Players Head office and Area Served
3.4 Key Players CD38 Monoclonal Antibodies Product Solution and Service
3.5 Date of Enter into CD38 Monoclonal Antibodies Market
3.6 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE (2015-2026)

4.1 Global CD38 Monoclonal Antibodies Historic Market Size by Type (2015-2020)
4.2 Global CD38 Monoclonal Antibodies Forecasted Market Size by Type (2021-2026)

5 MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global CD38 Monoclonal Antibodies Market Size by Application (2015-2020)
5.2 Global CD38 Monoclonal Antibodies Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America CD38 Monoclonal Antibodies Market Size (2015-2020)
6.2 CD38 Monoclonal Antibodies Key Players in North America (2019-2020)
6.3 North America CD38 Monoclonal Antibodies Market Size by Type (2015-2020)
6.4 North America CD38 Monoclonal Antibodies Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe CD38 Monoclonal Antibodies Market Size (2015-2020)
7.2 CD38 Monoclonal Antibodies Key Players in Europe (2019-2020)
7.3 Europe CD38 Monoclonal Antibodies Market Size by Type (2015-2020)
7.4 Europe CD38 Monoclonal Antibodies Market Size by Application (2015-2020)

8 CHINA

8.1 China CD38 Monoclonal Antibodies Market Size (2015-2020)
8.2 CD38 Monoclonal Antibodies Key Players in China (2019-2020)
8.3 China CD38 Monoclonal Antibodies Market Size by Type (2015-2020)
8.4 China CD38 Monoclonal Antibodies Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan CD38 Monoclonal Antibodies Market Size (2015-2020)
9.2 CD38 Monoclonal Antibodies Key Players in Japan (2019-2020)
9.3 Japan CD38 Monoclonal Antibodies Market Size by Type (2015-2020)
9.4 Japan CD38 Monoclonal Antibodies Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia CD38 Monoclonal Antibodies Market Size (2015-2020)
10.2 CD38 Monoclonal Antibodies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia CD38 Monoclonal Antibodies Market Size by Type (2015-2020)
10.4 Southeast Asia CD38 Monoclonal Antibodies Market Size by Application (2015-2020)

11 INDIA

11.1 India CD38 Monoclonal Antibodies Market Size (2015-2020)
11.2 CD38 Monoclonal Antibodies Key Players in India (2019-2020)
11.3 India CD38 Monoclonal Antibodies Market Size by Type (2015-2020)
11.4 India CD38 Monoclonal Antibodies Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America CD38 Monoclonal Antibodies Market Size (2015-2020)
12.2 CD38 Monoclonal Antibodies Key Players in Central & South America (2019-2020)
12.3 Central & South America CD38 Monoclonal Antibodies Market Size by Type (2015-2020)
12.4 Central & South America CD38 Monoclonal Antibodies Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 Johnson & Johnson
  13.1.1 Johnson & Johnson Company Details
  13.1.2 Johnson & Johnson Business Overview
  13.1.3 Johnson & Johnson CD38 Monoclonal Antibodies Introduction
  13.1.4 Johnson & Johnson Revenue in CD38 Monoclonal Antibodies Business (2015-2020))
  13.1.5 Johnson & Johnson Recent Development
13.2 Sanofi
  13.2.1 Sanofi Company Details
  13.2.2 Sanofi Business Overview
  13.2.3 Sanofi CD38 Monoclonal Antibodies Introduction
  13.2.4 Sanofi Revenue in CD38 Monoclonal Antibodies Business (2015-2020)
  13.2.5 Sanofi Recent Development
13.3 Janssen Biotech
  13.3.1 Janssen Biotech Company Details
  13.3.2 Janssen Biotech Business Overview
  13.3.3 Janssen Biotech CD38 Monoclonal Antibodies Introduction
  13.3.4 Janssen Biotech Revenue in CD38 Monoclonal Antibodies Business (2015-2020)
  13.3.5 Janssen Biotech Recent Development
13.4 Carbosynth
  13.4.1 Carbosynth Company Details
  13.4.2 Carbosynth Business Overview
  13.4.3 Carbosynth CD38 Monoclonal Antibodies Introduction
  13.4.4 Carbosynth Revenue in CD38 Monoclonal Antibodies Business (2015-2020)
  13.4.5 Carbosynth Recent Development
13.5 Creative Biolabs
  13.5.1 Creative Biolabs Company Details
  13.5.2 Creative Biolabs Business Overview
  13.5.3 Creative Biolabs CD38 Monoclonal Antibodies Introduction
  13.5.4 Creative Biolabs Revenue in CD38 Monoclonal Antibodies Business (2015-2020)
  13.5.5 Creative Biolabs Recent Development
13.6 BOC Sciences
  13.6.1 BOC Sciences Company Details
  13.6.2 BOC Sciences Business Overview
  13.6.3 BOC Sciences CD38 Monoclonal Antibodies Introduction
  13.6.4 BOC Sciences Revenue in CD38 Monoclonal Antibodies Business (2015-2020)
  13.6.5 BOC Sciences Recent Development

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. CD38 Monoclonal Antibodies Key Market Segments
Table 2. Key Players Covered: Ranking by CD38 Monoclonal Antibodies Revenue
Table 3. Ranking of Global Top CD38 Monoclonal Antibodies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global CD38 Monoclonal Antibodies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Daratumumab
Table 6. Key Players of Isatuximab
Table 7. Global CD38 Monoclonal Antibodies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global CD38 Monoclonal Antibodies Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global CD38 Monoclonal Antibodies Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global CD38 Monoclonal Antibodies Market Share by Regions (2015-2020)
Table 11. Global CD38 Monoclonal Antibodies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global CD38 Monoclonal Antibodies Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. CD38 Monoclonal Antibodies Market Growth Strategy
Table 17. Main Points Interviewed from Key CD38 Monoclonal Antibodies Players
Table 18. Global CD38 Monoclonal Antibodies Revenue by Players (2015-2020) (Million US$)
Table 19. Global CD38 Monoclonal Antibodies Market Share by Players (2015-2020)
Table 20. Global Top CD38 Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CD38 Monoclonal Antibodies as of 2019)
Table 21. Global CD38 Monoclonal Antibodies by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players CD38 Monoclonal Antibodies Product Solution and Service
Table 24. Date of Enter into CD38 Monoclonal Antibodies Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global CD38 Monoclonal Antibodies Market Size by Type (2015-2020) (Million US$)
Table 27. Global CD38 Monoclonal Antibodies Market Size Share by Type (2015-2020)
Table 28. Global CD38 Monoclonal Antibodies Revenue Market Share by Type (2021-2026)
Table 29. Global CD38 Monoclonal Antibodies Market Size Share by Application (2015-2020)
Table 30. Global CD38 Monoclonal Antibodies Market Size by Application (2015-2020) (Million US$)
Table 31. Global CD38 Monoclonal Antibodies Market Size Share by Application (2021-2026)
Table 32. North America Key Players CD38 Monoclonal Antibodies Revenue (2019-2020) (Million US$)
Table 33. North America Key Players CD38 Monoclonal Antibodies Market Share (2019-2020)
Table 34. North America CD38 Monoclonal Antibodies Market Size by Type (2015-2020) (Million US$)
Table 35. North America CD38 Monoclonal Antibodies Market Share by Type (2015-2020)
Table 36. North America CD38 Monoclonal Antibodies Market Size by Application (2015-2020) (Million US$)
Table 37. North America CD38 Monoclonal Antibodies Market Share by Application (2015-2020)
Table 38. Europe Key Players CD38 Monoclonal Antibodies Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players CD38 Monoclonal Antibodies Market Share (2019-2020)
Table 40. Europe CD38 Monoclonal Antibodies Market Size by Type (2015-2020) (Million US$)
Table 41. Europe CD38 Monoclonal Antibodies Market Share by Type (2015-2020)
Table 42. Europe CD38 Monoclonal Antibodies Market Size by Application (2015-2020) (Million US$)
Table 43. Europe CD38 Monoclonal Antibodies Market Share by Application (2015-2020)
Table 44. China Key Players CD38 Monoclonal Antibodies Revenue (2019-2020) (Million US$)
Table 45. China Key Players CD38 Monoclonal Antibodies Market Share (2019-2020)
Table 46. China CD38 Monoclonal Antibodies Market Size by Type (2015-2020) (Million US$)
Table 47. China CD38 Monoclonal Antibodies Market Share by Type (2015-2020)
Table 48. China CD38 Monoclonal Antibodies Market Size by Application (2015-2020) (Million US$)
Table 49. China CD38 Monoclonal Antibodies Market Share by Application (2015-2020)
Table 50. Japan Key Players CD38 Monoclonal Antibodies Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players CD38 Monoclonal Antibodies Market Share (2019-2020)
Table 52. Japan CD38 Monoclonal Antibodies Market Size by Type (2015-2020) (Million US$)
Table 53. Japan CD38 Monoclonal Antibodies Market Share by Type (2015-2020)
Table 54. Japan CD38 Monoclonal Antibodies Market Size by Application (2015-2020) (Million US$)
Table 55. Japan CD38 Monoclonal Antibodies Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players CD38 Monoclonal Antibodies Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players CD38 Monoclonal Antibodies Market Share (2019-2020)
Table 58. Southeast Asia CD38 Monoclonal Antibodies Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia CD38 Monoclonal Antibodies Market Share by Type (2015-2020)
Table 60. Southeast Asia CD38 Monoclonal Antibodies Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia CD38 Monoclonal Antibodies Market Share by Application (2015-2020)
Table 62. India Key Players CD38 Monoclonal Antibodies Revenue (2019-2020) (Million US$)
Table 63. India Key Players CD38 Monoclonal Antibodies Market Share (2019-2020)
Table 64. India CD38 Monoclonal Antibodies Market Size by Type (2015-2020) (Million US$)
Table 65. India CD38 Monoclonal Antibodies Market Share by Type (2015-2020)
Table 66. India CD38 Monoclonal Antibodies Market Size by Application (2015-2020) (Million US$)
Table 67. India CD38 Monoclonal Antibodies Market Share by Application (2015-2020)
Table 68. Central & South America Key Players CD38 Monoclonal Antibodies Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players CD38 Monoclonal Antibodies Market Share (2019-2020)
Table 70. Central & South America CD38 Monoclonal Antibodies Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America CD38 Monoclonal Antibodies Market Share by Type (2015-2020)
Table 72. Central & South America CD38 Monoclonal Antibodies Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America CD38 Monoclonal Antibodies Market Share by Application (2015-2020)
Table 74. Johnson & Johnson Company Details
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Product
Table 77. Johnson & Johnson Revenue in CD38 Monoclonal Antibodies Business (2015-2020) (Million US$)
Table 78. Johnson & Johnson Recent Development
Table 79. Sanofi Company Details
Table 80. Sanofi Business Overview
Table 81. Sanofi Product
Table 82. Sanofi Revenue in CD38 Monoclonal Antibodies Business (2015-2020) (Million US$)
Table 83. Sanofi Recent Development
Table 84. Janssen Biotech Company Details
Table 85. Janssen Biotech Business Overview
Table 86. Janssen Biotech Product
Table 87. Janssen Biotech Revenue in CD38 Monoclonal Antibodies Business (2015-2020) (Million US$)
Table 88. Janssen Biotech Recent Development
Table 89. Carbosynth Company Details
Table 90. Carbosynth Business Overview
Table 91. Carbosynth Product
Table 92. Carbosynth Revenue in CD38 Monoclonal Antibodies Business (2015-2020) (Million US$)
Table 93. Carbosynth Recent Development
Table 94. Creative Biolabs Company Details
Table 95. Creative Biolabs Business Overview
Table 96. Creative Biolabs Product
Table 97. Creative Biolabs Revenue in CD38 Monoclonal Antibodies Business (2015-2020) (Million US$)
Table 98. Creative Biolabs Recent Development
Table 99. BOC Sciences Company Details
Table 100. BOC Sciences Business Overview
Table 101. BOC Sciences Product
Table 102. BOC Sciences Revenue in CD38 Monoclonal Antibodies Business (2015-2020) (Million US$)
Table 103. BOC Sciences Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global CD38 Monoclonal Antibodies Market Share by Type: 2020 VS 2026
Figure 2. Daratumumab Features
Figure 3. Isatuximab Features
Figure 4. Global CD38 Monoclonal Antibodies Market Share by Application: 2020 VS 2026
Figure 5. Pharmacy Case Studies
Figure 6. Laboratory Use Case Studies
Figure 7. CD38 Monoclonal Antibodies Report Years Considered
Figure 8. Global CD38 Monoclonal Antibodies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global CD38 Monoclonal Antibodies Market Share by Regions: 2020 VS 2026
Figure 10. Global CD38 Monoclonal Antibodies Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global CD38 Monoclonal Antibodies Market Share by Players in 2019
Figure 13. Global Top CD38 Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CD38 Monoclonal Antibodies as of 2019
Figure 14. The Top 10 and 5 Players Market Share by CD38 Monoclonal Antibodies Revenue in 2019
Figure 15. North America CD38 Monoclonal Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe CD38 Monoclonal Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China CD38 Monoclonal Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan CD38 Monoclonal Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia CD38 Monoclonal Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India CD38 Monoclonal Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America CD38 Monoclonal Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed